New Mexico biologics regulations.
Who may administer PRP, exosomes and stem cells in New Mexico, and which agencies to check.

Who may administer biologics in New Mexico?
In New Mexico, practitioners administering stem cell therapies must be licensed healthcare providers. Licensed physicians (MDs or DOs) are authorized to conduct biologic treatments, while nurse practitioners or physician assistants may do so under physician supervision.
Official sources
New Mexico compliance guide.
FDA Compliance
The U.S. Food and Drug Administration (FDA) oversees the regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps), including stem cell therapies. Clinics in New Mexico must comply with FDA guidelines for HCT/P, which set standards for minimal manipulation, homologous use, and registration requirements for providers and manufacturers. Ensure that your clinic’s protocols align with these federal guidelines to maintain compliance.
New Mexico State Regulations
In addition to federal standards, clinics must adhere to New Mexico’s Department of Health regulations. While New Mexico does not have specific legislation exclusively for stem cell therapies, it enforces general medical and licensing laws that impact biologics. Understanding these requirements is key to establishing a compliant practice. Regularly review New Mexico health guidelines to stay updated on any emerging standards specific to biologics.
Provider Qualifications
In New Mexico, practitioners administering stem cell therapies must be licensed healthcare providers. Licensed physicians (MDs or DOs) are authorized to conduct biologic treatments, while nurse practitioners or physician assistants may do so under physician supervision. Refer to New Mexico Medical Board’s licensing requirements to ensure your team’s credentials align with state guidelines.
Patient Informed Consent
New Mexico clinics must ensure that patients understand the potential risks and benefits of biologic treatments. Informed consent documentation should outline:
- Procedure details and expected outcomes.
- Risks and potential adverse effects.
- Acknowledgement of the therapy's experimental nature (if applicable).
- Alternative treatment options.Emphasize transparency in all communications to enhance patient trust and comply with ethical standards.
Additional Compliance Measures
Pre-Treatment and Post-Treatment Protocols
Standardizing protocols for pre- and post-treatment enhances patient safety and regulatory compliance. Develop SOPs that include screening criteria, procedure steps, and follow-up care, documented in compliance with both FDA and state recommendations.
Insurance Requirements
Biologic therapies can pose risks that may impact liability. Clinics should ensure adequate coverage with medical liability insurance specific to biologic or stem cell therapies. Verify that your policy meets state requirements and covers all potential risks associated with these treatments.
Marketing Compliance
New Mexico requires that all clinic advertisements provide accurate and non-misleading information. Avoid unverified claims about the efficacy of stem cell treatments and adhere to FDA advertising guidelines. Clear and honest marketing is essential to maintain both compliance and patient trust.
This guide is a general summary to help clinics understand compliance requirements for biologics in New Mexico. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
New Mexico: common questions.
Who can administer stem cells, PRP and exosomes in New Mexico?
Are stem cell and exosome therapies FDA-approved in New Mexico?
Do I need an IRB-approved study to offer biologics in New Mexico?
How do I start offering biologics in New Mexico?
Practising in New Mexico? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.